S J Brown1,2, S M Langan3, S G Nicholls4, K Shams5, E Healy6,7, N J Reynolds8. 1. Department of Dermatology, Ninewells Hospital & Medical School, Dundee, UK. 2. Dermatology & Genetic Medicine, Medical Research Institute, University of Dundee, Dundee, UK. 3. Faculty of Epidemiology and Population Health, London School of Tropical Medicine, London, UK. 4. Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada. 5. Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. 6. Dermatopharmacology, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, UK. 7. Southampton Dermatology Centre, Royal South Hants Hospital, University Hospitals Southampton NHS Foundation Trust, Southampton, UK. 8. Dermatology, Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle upon Tyne, UK.
Abstract
BACKGROUND: Translational research is the direct application of basic and applied research to patient care. It is estimated that there are at least 2000 different skin diseases; thus, there are considerable challenges in seeking to undertake research on each of these disorders. OBJECTIVES: This electronic Delphi (e-Delphi) exercise was conducted in order to generate a list of translational dermatology research questions that are regarded as a priority for further investigations. METHODS: During the first phase of the e-Delphi exercise, 228 research questions were generated by an expert panel that included clinical academic dermatologists, clinical dermatologists, nonclinical scientists, dermatology trainees and representatives from patient support groups. RESULTS: Following completion of the second and third phases, 40 questions on inflammatory skin disease, 20 questions on structural skin disorders/genodermatoses, 37 questions on skin cancer and eight miscellaneous questions were designated as priority translational dermatology research questions (PRQs). In addition to PRQs on a variety of disease areas (including multiple PRQs on psoriasis, eczema, squamous cell carcinoma and melanoma), there were a number of cross-cutting themes that identified a need to investigate mechanisms/pathogenesis of disease and the necessity to improve treatments for patients with skin disease. CONCLUSIONS: It is predicted that this list of PRQs will help to provide a strategic direction for translational dermatology research in the U.K. and that addressing this list of questions will ultimately provide clinical benefit for substantial numbers of patients with skin disorders.
BACKGROUND: Translational research is the direct application of basic and applied research to patient care. It is estimated that there are at least 2000 different skin diseases; thus, there are considerable challenges in seeking to undertake research on each of these disorders. OBJECTIVES: This electronic Delphi (e-Delphi) exercise was conducted in order to generate a list of translational dermatology research questions that are regarded as a priority for further investigations. METHODS: During the first phase of the e-Delphi exercise, 228 research questions were generated by an expert panel that included clinical academic dermatologists, clinical dermatologists, nonclinical scientists, dermatology trainees and representatives from patient support groups. RESULTS: Following completion of the second and third phases, 40 questions on inflammatory skin disease, 20 questions on structural skin disorders/genodermatoses, 37 questions on skin cancer and eight miscellaneous questions were designated as priority translational dermatology research questions (PRQs). In addition to PRQs on a variety of disease areas (including multiple PRQs on psoriasis, eczema, squamous cell carcinoma and melanoma), there were a number of cross-cutting themes that identified a need to investigate mechanisms/pathogenesis of disease and the necessity to improve treatments for patients with skin disease. CONCLUSIONS: It is predicted that this list of PRQs will help to provide a strategic direction for translational dermatology research in the U.K. and that addressing this list of questions will ultimately provide clinical benefit for substantial numbers of patients with skin disorders.
Authors: John E Wagner; Akemi Ishida-Yamamoto; John A McGrath; Maria Hordinsky; Douglas R Keene; David T Woodley; Mei Chen; Megan J Riddle; Mark J Osborn; Troy Lund; Michelle Dolan; Bruce R Blazar; Jakub Tolar Journal: N Engl J Med Date: 2010-08-12 Impact factor: 91.245
Authors: Klaus G Griewank; Richard A Scolyer; John F Thompson; Keith T Flaherty; Dirk Schadendorf; Rajmohan Murali Journal: J Natl Cancer Inst Date: 2014-02 Impact factor: 13.506
Authors: Roderick J Hay; Nicole E Johns; Hywel C Williams; Ian W Bolliger; Robert P Dellavalle; David J Margolis; Robin Marks; Luigi Naldi; Martin A Weinstock; Sarah K Wulf; Catherine Michaud; Christopher J L Murray; Mohsen Naghavi Journal: J Invest Dermatol Date: 2013-10-28 Impact factor: 8.551
Authors: Zoë C Venables; Philippe Autier; Tamar Nijsten; Kwok F Wong; Sinéad M Langan; Brian Rous; John Broggio; Catherine Harwood; Katherine Henson; Charlotte M Proby; Jem Rashbass; Irene M Leigh Journal: JAMA Dermatol Date: 2019-03-01 Impact factor: 10.282
Authors: Bingjie Wang; Brian J McHugh; Ayub Qureshi; Dominic J Campopiano; David J Clarke; J Ross Fitzgerald; Julia R Dorin; Richard Weller; Donald J Davidson Journal: J Invest Dermatol Date: 2016-10-01 Impact factor: 8.551
Authors: Z C Venables; T Nijsten; K F Wong; P Autier; J Broggio; A Deas; C A Harwood; L M Hollestein; S M Langan; E Morgan; C M Proby; J Rashbass; I M Leigh Journal: Br J Dermatol Date: 2019-05-06 Impact factor: 9.302
Authors: K Abuabara; S G Nicholls; S M Langan; E Guttman-Yassky; N J Reynolds; A S Paller; S J Brown Journal: Br J Dermatol Date: 2021-04-07 Impact factor: 11.113